Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice
about
Therapeutic roles of heme oxygenase-1 in metabolic diseases: curcumin and resveratrol analogues as possible inducers of heme oxygenase-1Highly stabilized curcumin nanoparticles tested in an in vitro blood-brain barrier model and in Alzheimer's disease Tg2576 miceOral administration of nano-emulsion curcumin in mice suppresses inflammatory-induced NFκB signaling and macrophage migration.Co-delivery of natural metabolic inhibitors in a self-microemulsifying drug delivery system for improved oral bioavailability of curcumin.Curcumin down-regulates DNA methyltransferase 1 and plays an anti-leukemic role in acute myeloid leukemia.Demethoxycurcumin Retards Cell Growth and Induces Apoptosis in Human Brain Malignant Glioma GBM 8401 CellsCurcumin decreases malignant characteristics of glioblastoma stem cells via induction of reactive oxygen species.Curcumin-cyclodextrin complexes potentiate gemcitabine effects in an orthotopic mouse model of lung cancer.Preclinical In Vitro, In Vivo, and Pharmacokinetic Evaluations of FLLL12 for the Prevention and Treatment of Head and Neck Cancers.Silica-coated flexible liposomes as a nanohybrid delivery system for enhanced oral bioavailability of curcuminOral or parenteral administration of curcumin does not prevent the growth of high-risk t(4;11) acute lymphoblastic leukemia cells engrafted into a NOD/SCID mouse model.Antidiabetic potential of the heme oxygenase-1 inducer curcumin analogues.Future directions in the prevention of prostate cancer.Phytobioactive compound-based nanodelivery systems for the treatment of type 2 diabetes mellitus - current status.Oral intake of curcumin markedly activated CYP 3A4: in vivo and ex-vivo studies.Recent developments in delivery, bioavailability, absorption and metabolism of curcumin: the golden pigment from golden spice.Recent advances in curcumin nanoformulation for cancer therapy.Curcumin and chronic kidney disease (CKD): major mode of action through stimulating endogenous intestinal alkaline phosphatase.Curcumin and inflammatory bowel disease: potential and limits of innovative treatments.A review of the efficacy of dietary polyphenols in experimental models of inflammatory bowel diseases.Orally delivered polycurcumin responsive to bacterial reduction for targeted therapy of inflammatory bowel disease.Metabolic fate of poly-(lactic-co-glycolic acid)-based curcumin nanoparticles following oral administration.Curcumin-polymeric nanoparticles against colon-26 tumor-bearing mice: cytotoxicity, pharmacokinetic and anticancer efficacy studies.Insights into the percutaneous penetration of antidiabetic agents.Differential cellular uptake and metabolism of curcuminoids in monocytes/macrophages: regulatory effects on lipid accumulation.Protective effects of curcumin against genotoxicity induced by 131-iodine in human cultured lymphocyte cells.Curcumin Pharmacokinetic and Pharmacodynamic Evidences in Streptozotocin-Diabetic Rats Support the Antidiabetic Activity to Be via Metabolite(s).Comparative analysis of protective effects of curcumin, curcumin-β-cyclodextrin nanoparticle and nanoliposomal curcumin on unsymmetrical dimethyl hydrazine poisoning in mice.Microparticles Containing Curcumin Solid Dispersion: Stability, Bioavailability and Anti-Inflammatory Activity.Bisdemethoxycurcumin inhibits PDGF-induced vascular smooth muscle cell motility and proliferation.Evaluation of the in vivo acute antiinflammatory response of curcumin-loaded nanoparticles.Curcumin as a functional food-derived factor: degradation products, metabolites, bioactivity, and future perspectives.Pharmacokinetics of Curcumin Diethyl Disuccinate, a Prodrug of Curcumin, in Wistar Rats.Disposition, Metabolism and Histone Deacetylase and Acetyltransferase Inhibition Activity of Tetrahydrocurcumin and Other Curcuminoids.Curcumin and Viscum album Extract Decrease Proliferation and Cell Viability of Soft-Tissue Sarcoma Cells: An In Vitro Analysis of Eight Cell Lines Using Real-Time Monitoring and Colorimetric Assays.Antioxidant response and biocompatibility of curcumin-loaded triblock copolymeric micelles.Formulation, in-vitro characterization and clinical evaluation of curcumin in-situ gel for treatment of periodontitis.Structure- and isoform-specific glucuronidation of six curcumin analogs.Curcumin's Metabolites, Tetrahydrocurcumin and Octahydrocurcumin, Possess Superior Anti-inflammatory Effects Through Suppression of TAK1-NF-κB Pathway
P2860
Q27021350-BC3DBE09-9634-401E-8916-5A5F693817C8Q30540417-E9CED209-53F7-4830-ACF6-76060FFF7DE9Q34450324-C706E165-682D-4603-910F-2E158709A3A8Q34554669-18A87C85-C40E-4666-B0DB-A647507B9CBDQ34606426-3BAACB48-F270-4FB6-A385-5FE3779B4D89Q35792692-078119F0-11E3-49CC-A931-313595B2DB3CQ36270652-2A851315-1395-4072-B911-FF2942EF7AA4Q36288018-7DDC407C-08FA-4300-9C10-CD55030ED0A6Q36446689-182FD47A-2773-46EC-A3C1-5D87B5A1D4B5Q36458029-8A03C31B-E5A3-4B70-A7C9-9313285D1A96Q36643470-9969911F-A8B2-4E56-91D7-F60B2FB70158Q37244395-3C748F16-8883-45C3-80EE-3EFFF72B8561Q37279094-D87CCF78-4A38-4308-9378-FF1D38581E6CQ37643472-CA252069-93AC-48E2-B36B-F3955BD53A48Q37734897-A4611CC9-EAAD-4EEC-A657-71CE48C5E542Q38187406-8CD5E53C-6403-4D2D-83A9-B0361797AEC2Q38214381-DD16FB55-F80A-4DDF-931F-DB2DBE6F31BBQ38283016-7A860682-5A58-4FD4-92D5-7F58BAB74ABCQ38292885-92596222-2857-462B-90DA-9F1637B9E6CCQ38489805-2FF765C2-A9AF-4D73-8792-5D95741FEEB1Q38718154-5273CF15-F6DB-4D09-B583-6404CF73A06AQ38841668-579A779F-BF5C-4412-B869-B4535FFFF380Q38854189-0056E0E6-4794-47FB-B244-A80014236EA7Q38921153-1A0DE4FE-22FB-4E29-8FD0-2CB19AE5FF19Q39005096-152C9F8B-CF0E-4E39-A783-AFD9A3A9C267Q40409652-CEEEBB75-6C47-4B2B-9824-0BC5CD3180B9Q40728869-0C887BC2-21C8-4853-A764-4178DF4C90D7Q41439574-10F5CD1E-8978-4444-A901-E6FEB700941BQ41987467-159F308C-70F3-449C-A26D-E76064165B6CQ42859208-9310B15B-587E-4ECA-9DB4-955672BFCF9CQ47262624-636E8E57-1DF4-4FEC-906A-C24F76AC7849Q47769067-E8D1F86A-0C3C-40CB-98EB-5AD5F3DAAD88Q48105359-B95F8C3E-D8CC-4326-88FD-A895E6EB468AQ48204217-65AD569E-2A74-4DD6-8841-0C19716C0262Q50976238-5B2AB4FF-6163-4668-A7C1-8F8676EA0FD3Q51744735-40A733F7-7727-4D9D-933C-12232D77E2C0Q51843044-9A141B00-D661-4B0B-82E7-069DB323B853Q52863201-13A2AFE7-BF2E-477C-9BAD-12310B1A3CDDQ58606486-E7CADB7D-E478-4B86-9F83-2430D12BB858
P2860
Enhancement of curcumin oral absorption and pharmacokinetics of curcuminoids and curcumin metabolites in mice
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
2011年论文
@zh
2011年论文
@zh-cn
name
Enhancement of curcumin oral a ...... d curcumin metabolites in mice
@ast
Enhancement of curcumin oral a ...... d curcumin metabolites in mice
@en
type
label
Enhancement of curcumin oral a ...... d curcumin metabolites in mice
@ast
Enhancement of curcumin oral a ...... d curcumin metabolites in mice
@en
prefLabel
Enhancement of curcumin oral a ...... d curcumin metabolites in mice
@ast
Enhancement of curcumin oral a ...... d curcumin metabolites in mice
@en
P2093
P2860
P1476
Enhancement of curcumin oral a ...... d curcumin metabolites in mice
@en
P2093
Jiang Wang
Kenneth K Chan
Lisa D Yee
Liu Zhongfa
Patty Fan-Havard
Winston Yen
P2860
P2888
P304
P356
10.1007/S00280-011-1749-Y
P577
2011-10-04T00:00:00Z